"Most importantly he said that the issue for Cynata is that the potential for the cells to differentiate into a cancerous cell"
SI is full of it.....he needs to get his head out of the sand.
C is not genetically modifying cells for a start AND they have a patented purifying process that has zero residual IPSCs in the MSCs...and that furpy has already been done to death here with facts...
SIs MSB GEN 1 cell tech harvesting and expansion is "dark ages" tech....past it before he's even started selling a cell
Monash just proved how much more consistent and potent iPSC derived MSCs are compared to Bone Marrow.
SI should be worried.
I think the FDA has already let him know
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-298
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |